search
Back to results

TRAUMEEL for Pain After Fracture of Neck of Femur

Primary Purpose

Pain, Fracture of Neck of Femur

Status
Withdrawn
Phase
Phase 3
Locations
Israel
Study Type
Interventional
Intervention
Traumeel S
Placebo remedy
Sponsored by
Shaare Zedek Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring homeopathy, pain, traumeel s, Fracture of neck of femur, Surgical correction of fracture of neck of hip

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients of either sex undergoing surgical correction of unilateral fracture of neck of hip. Age over 18 years. Signature upon informed consent form Exclusion Criteria: Participation in another clinical trial within 4 weeks prior to enrollment. Refused to give verbal consent to the telephone interviews Impossibility to be reached during the 14-17 days post operative Inability to comply with the study protocol for any other reason Previous major surgical procedure on ipsilateral hip. Current use of analgesics for any other reason. A history of chronic pain syndrome. Abused legal or illicit drug use. Hypersensitivity to botanicals of the Compositae family Known sensitivity to paracetamol, codeine or tramadol.

Sites / Locations

  • Dept. of Orthopedic Surgery, Shaare Zedek Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

A

B

Arm Description

TRAUMEEL S

placebo remedy

Outcomes

Primary Outcome Measures

Cumulative 48-hour postoperative morphine consumption

Secondary Outcome Measures

Secondary: AUC of NRS scores for first 48 hrs.;
AUC of NRS scores for days 14-17.;
Composite measure of pain intensity and opiate consumption;
Number of primary oral analgesic tablets ingested between days 14-17;
ESR and hs-CPR at three and six days and six weeks;
IL-6 at three and six days;
Post operative blood loss;
WOMAC;
Safety of post operative treatment

Full Information

First Posted
March 27, 2006
Last Updated
October 28, 2010
Sponsor
Shaare Zedek Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00307905
Brief Title
TRAUMEEL for Pain After Fracture of Neck of Femur
Official Title
A Randomised, Double - Blind, Placebo Controlled Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Controlling Post-operative Pain After Fracture of Neck of Femur
Study Type
Interventional

2. Study Status

Record Verification Date
October 2010
Overall Recruitment Status
Withdrawn
Why Stopped
Anticipation of inadequate recruitment according to current format.
Study Start Date
January 2011 (undefined)
Primary Completion Date
June 2012 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Shaare Zedek Medical Center

4. Oversight

5. Study Description

Brief Summary
We hypothesize that Traumeel S is more effective than placebo in reducing 48-hour mean cumulative morphine consumption in patients scheduled for surgical correction of fracture of neck of hip. 224 patients, meeting all inclusion and none of exclusion criteria, will be enrolled in the trial. Patients will be randomized to receive either intraoperative injection and post operative oral Traumeel S Tablets or placebo injection (normal saline) and indistinguishable oral placebo tablets. Baseline measurements of relevant outcome measures will taken preoperatively. Immediately after surgery, patients will receive an initial dose of morphine of 0.1mg/kg body weight. Patients will take the oral study medication for 21 days. Every four hours after surgery, patients will be asked to grade their pain on an NRS. Subsequent doses of morphine will be calculated based upon the patient's weight and current NRS, according to a preplanned scheme. Patients will be permitted to request additional morphine, beyond their calculated dose.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Fracture of Neck of Femur
Keywords
homeopathy, pain, traumeel s, Fracture of neck of femur, Surgical correction of fracture of neck of hip

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
224 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A
Arm Type
Active Comparator
Arm Description
TRAUMEEL S
Arm Title
B
Arm Type
Placebo Comparator
Arm Description
placebo remedy
Intervention Type
Drug
Intervention Name(s)
Traumeel S
Intervention Description
homeopathic remedy
Intervention Type
Drug
Intervention Name(s)
Placebo remedy
Intervention Description
identical size, shape and taste of treatment medication
Primary Outcome Measure Information:
Title
Cumulative 48-hour postoperative morphine consumption
Time Frame
48h
Secondary Outcome Measure Information:
Title
Secondary: AUC of NRS scores for first 48 hrs.;
Time Frame
48h
Title
AUC of NRS scores for days 14-17.;
Time Frame
17d
Title
Composite measure of pain intensity and opiate consumption;
Time Frame
17d
Title
Number of primary oral analgesic tablets ingested between days 14-17;
Time Frame
17d
Title
ESR and hs-CPR at three and six days and six weeks;
Time Frame
42d
Title
IL-6 at three and six days;
Time Frame
6d
Title
Post operative blood loss;
Time Frame
48h
Title
WOMAC;
Time Frame
17d
Title
Safety of post operative treatment
Time Frame
17d

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients of either sex undergoing surgical correction of unilateral fracture of neck of hip. Age over 18 years. Signature upon informed consent form Exclusion Criteria: Participation in another clinical trial within 4 weeks prior to enrollment. Refused to give verbal consent to the telephone interviews Impossibility to be reached during the 14-17 days post operative Inability to comply with the study protocol for any other reason Previous major surgical procedure on ipsilateral hip. Current use of analgesics for any other reason. A history of chronic pain syndrome. Abused legal or illicit drug use. Hypersensitivity to botanicals of the Compositae family Known sensitivity to paracetamol, codeine or tramadol.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Menachem Oberbaum, MD
Organizational Affiliation
Shaare Zedek Medical Center, Jerusalem, Israel
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept. of Orthopedic Surgery, Shaare Zedek Medical Center
City
Jerusalem
Country
Israel

12. IPD Sharing Statement

Learn more about this trial

TRAUMEEL for Pain After Fracture of Neck of Femur

We'll reach out to this number within 24 hrs